Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Clinical trial NCT02015481 · COMPLETED
Trial details
- NCT number
- NCT02015481
- Sponsor
- Bioblast Pharma Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.